Saußele, S
Richter, J
Hochhaus, A
Mahon, F-X
Article History
Received: 22 February 2016
Revised: 22 March 2016
Accepted: 30 March 2016
First Online: 2 May 2016
Competing interests
: SS received honoraria from Novartis, Bristol-Myers Squibb (BMS), Pfizer, ARIAD and research funding from Novartis and BMS; JR research support and/or honoraria by Novartis, BMS, Pfizer and Ariad; AH research support and honoraria by Novartis, BMS, Pfizer and Ariad, and FXM research support and/or honoraria by Novartis, BMS, Pfizer and Ariad.